Elisa Schrader Echeverri

Statistics

Publications

Citations

1.1K

H-Index

Active since

2021

Affiliations

Georgia Institute of Technology(Current)

The Wallace H. Coulter Department of Biomedical Engineering

Emory University

Leiden University Medical Center

Inserm

Elisa Schrader Echeverri is an author at Georgia Institute of Technology specializing in lipid nanoparticles, molecular biology, and lipid-based nanoparticles.

ORCID

Publications per year

2021–2025

Publications

Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs

Melissa P. Lokugamage, Daryll Vanover, Jared Beyersdorf et al. · Nature Biomedical Engineering · 2021 · 466 citations · Full text

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +14

Nanoparticle single-cell multiomic readouts reveal that cell heterogeneity influences lipid nanoparticle-mediated messenger RNA delivery

Curtis Dobrowolski, Kalina Paunovska, Elisa Schrader Echeverri et al. · Nature Nanotechnology · 2022 · 98 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

Augmented lipid-nanoparticle-mediated in vivo genome editing in the lungs and spleen by disrupting Cas9 activity in the liver

Cory D. Sago, Melissa P. Lokugamage, David Loughrey et al. · Nature Biomedical Engineering · 2022 · 77 citations

Life Sciences, Biotechnology, Molecular Genetics +14

The Transcriptional Response to Lung-Targeting Lipid Nanoparticles <i>in Vivo</i>

Afsane Radmand, Melissa P. Lokugamage, Hyejin Kim et al. · Nano Letters · 2023 · 67 citations · Full text

Pharmacy, Molecular Biology, Pharmaceutics +17

High-throughput screens identify a lipid nanoparticle that preferentially delivers mRNA to human tumors in vivo

Sebastian G. Huayamares, Melissa P. Lokugamage, Regina Rab et al. · Journal of Controlled Release · 2023 · 65 citations · Full text

Pharmacy, Molecular Biology, Oncology +16

1–5 of 17